Supriya Lifescience aims for 20% annual revenue growth with steady margins
Backward integration, regulated market expansion, and new contracts to drive growth, says MD Saloni Wagh.
Backward integration, regulated market expansion, and new contracts to drive growth, says MD Saloni Wagh.
What's Your Reaction?



